enhancing immunotherapy efficacy in bladder cancer
Published 5 months ago • 76 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
1:21
how can we improve responses to immunotherapy in patients with bladder cancer?
-
0:28
immunotherapy chemotherapy for bladder cancer
-
0:54
addressing the unmet needs of immunotherapy in bladder cancer
-
0:44
role of immunotherapy in bladder cancer
-
2:50
enhancing the efficacy of immunotherapy in lung cancer
-
1:10
the difficulties in treating bladder cancer with immunotherapy
-
1:44
incorporating patient experiences in bladder cancer treatment: enhancing outcomes and qol
-
1:10
highlights in bladder cancer from asco 2022
-
3:31
the use of immunotherapy as a first-line therapy for bladder cancer
-
1:46
adverse events in bladder cancer immunotherapy
-
6:08
immunotherapy approaches for nmibc
-
1:25
progress and challenges of immunotherapy for bladder cancer
-
1:50
potentiating immunotherapy for bladder cancer via porphyrin-based plz4-nanoparticles
-
3:27
improving anti-pd-1/pd-l1 therapy for localized bladder cancer
-
1:20
unmet needs of immunotherapy for bladder cancer
-
0:58
unmet needs in regards to immunotherapy for bladder cancer
-
1:12
asco gu 2023: moving immunotherapy into the first-line setting for bladder cancer
-
0:44
unmet needs in bladder cancer in the immunotherapy era
-
2:22
keynote-057: extended follow-up of pembrolizumab in bladder cancer